Affiliation:
1. School of Bioscience and Biotechnology, Tokyo University of Technology
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference27 articles.
1. 1) Pechtner V, Karanikas CA, García-Pérez LE, Glaesner W. A new approach to drug therapy: Fc-fusion technology. Prim. Health Care, 7, 1000255 (2017).
2. 2) Czajkowsky DM, Hu J, Shao Z, Pleass RJ. Fc-fusion proteins: new developments and future perspectives. EMBO Mol. Med., 4, 1015–1028 (2012).
3. 3) Shiga Y, Murata D, Sugimoto A, Oshima Y, Tada M, Ishii-Watabe A, Imai K, Tomii K, Takeuchi T, Kagaya S, Sato A. Hinge-deficient IgG1 Fc fusion: application to human lactoferrin. Mol. Pharm., 14, 3025–3035 (2017).
4. 4) Liu H, May K. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. MAbs, 4, 17–23 (2012).
5. 5) Jo M, Kwon HS, Lee KH, Lee JC, Jung ST. Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance. MAbs, 10, 278–289 (2018).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献